Annapolis, MD (January 13, 2020) —The Global Board of Directors of the Plasma Protein Therapeutics Association(PPTA) elected Karen Etchberger of CSL Behring as its Chair, effective January 2020. Dr. Etchberger will serve a three-year term and succeeds outgoing Chair, David Bell, Grifols S.A.

The Plasma Protein Therapeutics Association (PPTA) announced today that Maarten Van Baelen has joined the association as Executive Director, PPTA Europe. Maarten brings to PPTA more than 10 years in the life sciences arena, including as an advocate for access to generic, biosimilar and value-added medicines.  He has represented the pharmaceutical sector’s interest in public forums, strategic policy development, and advocacy on key issues with the European Commission, National Competent Authorities, and other stakeholders.

Annapolis, MD (January 14, 2019) -- The Board of Directors of the Plasma Protein Therapeutics Association (PPTA) announced today that Amy Efantis will be its next President and Chief Executive Officer effective January 16, 2019.

Having served most recently as Vice President, Global Public Policy & Government Affairs at Biogen, Efantis joins the PPTA, the world’s leading trade association that represents more than 750 human plasma collection centers in North America and Europe as well as the manufacturers of life-saving plasma protein therapies.

ANNAPOLIS, MD (October 8, 2018) — Today, in conjunction with its member companies, the Plasma Protein Therapeutics Association (PPTA) launched the sixth annual International Plasma Awareness Week (IPAW), a globally recognized opportunity to raise awareness of plasma collection and how lifesaving plasma protein therapies are derived from plasma donations.

“How Is Your Day?” highlights value of plasma protein therapies in improving patients’ lives

Budapest, HUNGARY (March 13)– The Plasma Protein Therapeutics Association (PPTA) today unveiled its new global initiative, “How Is Your Day?” –Making the difference with plasma proteins, in conjunction with the annual International Plasma Protein Congress. “How Is Your Day?” will focus on differentiating these unique therapies from traditional pharmaceuticals and building awareness of the value they provide for people living with rare, life-threatening, chronic, and genetic diseases.

Annual IPAW celebration calls attention to importance of plasma donation to save lives
ANNAPOLIS, MD (October 12, 2017) — The Plasma Protein Therapeutics Association (PPTA) applauds Representative Doris Matsui (CA-6) for recognizing International Plasma Awareness Week (IPAW) with a statement in the Congressional Record noting these therapies “save and improve lives of individuals throughout the world [and] have significantly improved the quality of life, markedly improved patient outcomes, and extended the life expectancy of individuals with rare, chronic diseases and conditions.”

Annapolis, MD--The fifth annual International Plasma Awareness Week (IPAW) will be celebrated October 8-14. A joint initiative of the Plasma Protein Therapeutics Association (PPTA) and its member companies, IPAW is designed to:

ANNAPOLIS, Md., Oct. 9, 2016 /PRNewswire/ -- The Plasma Protein Therapeutics Association (PPTA) and its member companies are sponsoring International Plasma Awareness Week, October 9-15 designed to:

The Plasma Protein Therapeutics Association (PPTA) Global Board of Directors elected Mr. David Ian Bell as the new Chairman, effective January 2016. Mr. Bell will serve as Chairman for a term of three years.

Annapolis, MD—The Plasma Protein Therapeutics Association (PPTA) and its member companies are sponsoring International Plasma Awareness Week, October 11-17 designed to: